Volume :

3

Issue :

2

Abstract :

Atropine is an anti-cholinergic, prototype of drug obtained from Atropa Belladonna. It mainly blocks the muscarinic receptors which place a major role in performance of the brain for learning, memory, and orientation. In the therapeutic dose, atropine has a mild CNS stimulant effect but large doses can produce excitement, restlessness, agitation, hallucinations, coma and death. In therapeutic dose of atropine produces tachycardia through the blockage of M2 receptors of the heart. The use of atropine includes, brad arrhythmias, Severe bradycardia, organophosphate poisoning, 1st degree A-V block, salivary and bronchial secretion reduction. the extreme doses of atropine can causes the tachycardia, delirium, coma, flushed and hot skin, blurred vision, excitement, restlessness, hallucinations and ataxia. Here in this case report, a 30 years old female patient was developed excitement, hallucinations, restlessness, blurring of vision, photophobia, tachycardia, palpitation medullary paralysis and ECG abnormalities due to the atropine administration.